Literature DB >> 33520823

The effect of Faecalibacterium prausnitzii and its extracellular vesicles on the permeability of intestinal epithelial cells and expression of PPARs and ANGPTL4 in the Caco-2 cell culture model.

Seyedeh Marzieh Moosavi1, Abbas Akhavan Sepahi1, Seyed Fazlollah Mousavi2,3, Farzam Vaziri4,3, Seyed Davar Siadat4,3.   

Abstract

BACKGROUND AND OBJECTIVES: Gut microbiota such as Faecalibacterium prausnitzii play a major role in the regulation of gut barrier, inflammation and metabolic functions. Microbiota-derived extracellular vehicles (EVs) have been recently introduced as functional units mediating the eukaryotic and prokaryotic cell-microbiota interactions. In this paper, the effect of F. prausnitzii and its EVs on mRNA expression levels of tight junction genes (ZO1 and OCLN) as well as PPARs and ANGPTL4 genes in the human epithelial colorectal adenocarcinoma (Caco-2) cell line was evaluated.
METHODS: F. prausnitzii was cultured on the Brain Heart Infusion (BHI) broth medium under anaerobic conditions, and its EVs were extracted by ultracentrifugation. This bacterium and its EVs were treated on the Caco-2 cells. After 24 h, the expression of the genes encoding TJ proteins such as ZO1 and OCLN, PPARs and ANGPTL4 was evaluated by quantitative real-time PCR.
RESULTS: Unlike F. prausnitzii, its EVs significantly increased the expression of ZO1 and OCLN genes, and PPARα, PPARγ and PPARβ/δ genes (except at a concentration of 100 µg/ml) as well as ANGPTL4 gene.
CONCLUSIONS: The results of this study demonstrated that F. prausnitzii-derived EVs increased the intestinal barrier permeability via TJs (ZO1 and OCLN) as well as PPAR-α, PPAR-γ and PPAR β/δ genes and their targeted gene (ANGPTL4) in the Caco-2 cell line. Accordingly, it is suggested that F. prausnitzii-derived EVs can be considered as a new bacterial postbiotic to cure dysbiosis-associated diseases including obesity and its related metabolic dysfunctions, according to the leaky gut hypothesis. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  ANGPTL4; EVs; F. prausnitzii; Intestinal epithelial cell permeability; PPARs

Year:  2020        PMID: 33520823      PMCID: PMC7843710          DOI: 10.1007/s40200-020-00605-1

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  68 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 2.  Regulation of tight junction permeability by intestinal bacteria and dietary components.

Authors:  Dulantha Ulluwishewa; Rachel C Anderson; Warren C McNabb; Paul J Moughan; Jerry M Wells; Nicole C Roy
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

3.  Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.

Authors:  Xinxin Yu; Shawn C Burgess; Hongfei Ge; Kenny K Wong; R Haris Nassem; Daniel J Garry; A Dean Sherry; Craig R Malloy; Joel P Berger; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

4.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

5.  Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.

Authors:  M Adachi; R Kurotani; K Morimura; Y Shah; M Sanford; B B Madison; D L Gumucio; H E Marin; J M Peters; H A Young; F J Gonzalez
Journal:  Gut       Date:  2006-03-17       Impact factor: 23.059

6.  Richness of human gut microbiome correlates with metabolic markers.

Authors:  Emmanuelle Le Chatelier; Trine Nielsen; Junjie Qin; Edi Prifti; Falk Hildebrand; Gwen Falony; Mathieu Almeida; Manimozhiyan Arumugam; Jean-Michel Batto; Sean Kennedy; Pierre Leonard; Junhua Li; Kristoffer Burgdorf; Niels Grarup; Torben Jørgensen; Ivan Brandslund; Henrik Bjørn Nielsen; Agnieszka S Juncker; Marcelo Bertalan; Florence Levenez; Nicolas Pons; Simon Rasmussen; Shinichi Sunagawa; Julien Tap; Sebastian Tims; Erwin G Zoetendal; Søren Brunak; Karine Clément; Joël Doré; Michiel Kleerebezem; Karsten Kristiansen; Pierre Renault; Thomas Sicheritz-Ponten; Willem M de Vos; Jean-Daniel Zucker; Jeroen Raes; Torben Hansen; Peer Bork; Jun Wang; S Dusko Ehrlich; Oluf Pedersen
Journal:  Nature       Date:  2013-08-29       Impact factor: 49.962

7.  Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe.

Authors:  Almut Heinken; M Tanweer Khan; Giuseppe Paglia; Dmitry A Rodionov; Hermie J M Harmsen; Ines Thiele
Journal:  J Bacteriol       Date:  2014-07-07       Impact factor: 3.490

8.  The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.

Authors:  Lu Shan; Xuan-Chuan Yu; Ziye Liu; Yi Hu; Lydia T Sturgis; Maricar L Miranda; Qingyun Liu
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

9.  Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.

Authors:  María José Fábrega; Laura Aguilera; Rosa Giménez; Encarna Varela; María Alexandra Cañas; María Antolín; Josefa Badía; Laura Baldomà
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

Review 10.  Interactions between Host PPARs and Gut Microbiota in Health and Disease.

Authors:  Arif Ul Hasan; Asadur Rahman; Hiroyuki Kobori
Journal:  Int J Mol Sci       Date:  2019-01-17       Impact factor: 5.923

View more
  1 in total

Review 1.  Looking into key bacterial proteins involved in gut dysbiosis.

Authors:  Xin-Yu Zeng; Ming Li
Journal:  World J Methodol       Date:  2021-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.